Furthermore, the activation of the PKC pathway by E2 through ERα‐36 leads to the suppression of JNK activity, thereby contributing to the induction of anti‐apoptotic mechanisms and cancer progression [10]. The gene discussed is PRRT2; the disease is cancer.